Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
About this item
Full title
Author / Creator
Kuppen, Malou CP , Westgeest, Hans M , van der Doelen, Maarten J , van den Eertwegh, Alphonsus JM , Coenen, Jules LLM , Aben, Katja KH , van den Bergh, Alphons CM , Bergman, Andries M , den Bosch, Joan van , Celik, Filiz , Hendriks, Mathijs P , Lavalaye, Jules , der Meer, Saskia van , Polee, Marco B , Somford, Diederik M , van Oort, Inge M , Uyl-de Groot, Carin A and Gerritsen, Winald R
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Timing of radium-223 (Ra-223) in metastatic castration-resistant prostate cancer (mCRPC) remains challenging due to alternative options and short window of opportunity.
: Ra-223 treated patients in the CAPRI-registry were included. Outcomes were evaluated based on treatment line of Ra-223.
Out of 285 patients, 49% received Ra-223 in line ≥3....
Alternative Titles
Full title
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
Authors, Artists and Contributors
Author / Creator
Westgeest, Hans M
van der Doelen, Maarten J
van den Eertwegh, Alphonsus JM
Coenen, Jules LLM
Aben, Katja KH
van den Bergh, Alphons CM
Bergman, Andries M
den Bosch, Joan van
Celik, Filiz
Hendriks, Mathijs P
Lavalaye, Jules
der Meer, Saskia van
Polee, Marco B
Somford, Diederik M
van Oort, Inge M
Uyl-de Groot, Carin A
Gerritsen, Winald R
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2408192252
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2408192252
Other Identifiers
ISSN
1479-6694
E-ISSN
1744-8301
DOI
10.2217/fon-2020-0039
